The tumor blood vessel as an ideal target for macromolecular anticancer agents

Journal of Controlled Release

Volumn 19, Issue 1-3, 1992, Pages 315-324

  Maeda, Hiroshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer drug; Macromolecular anticancer agent; SMANCS; Tumor blood vessel; Tumor targeting

Indexed keywords

ANTINEOPLASTIC AGENT; IODINATED POPPYSEED OIL; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOAVAILABILITY; BLOOD VESSEL; CONFERENCE PAPER; DRUG RELEASE; DRUG TARGETING; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

EID: 0026535566     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(92)90086-7     Document Type: Article

References (32)

1. Cancer selective macromolecular therapeusis: tailoring of an antitumor protein drug
2. Chemical modification of Superoxide dismutase. Extension of plasma half-life of the enzyme through its reversible binding to the circulating albumin
3. Tailor-making of protein drugs by polymer conjugation for tumor targetting. A brief review on smancs
4. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
5. Tumoritropic and lymphotropic principles of macromolecular drugs
6. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
7. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image
8. Medial regression and its functional significance in tumor-supplying host arteries
9. Microvascular architecture of experimental colon tumors in rats
10. Mechanism of localization of gallium-67 in tumors
11. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules
12. Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
13. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium
14. Synthetic polymers with intrinsic anticancer activity
15. Antitumor activity of mitomycin C-dextran conjugate against various murine tumors
16. Antitumor activity of daunorubicin linked to poly L-aspartic acid
17. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolase, as required for a lysomotropic drug-carrier conjugate: in vitro and in vivo studies
18. Soluble synthetic polymers as potential drug carriers
19. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model
20. Synthesis of antitumor-active conjugate of adriamycin or daunomycin with the copolymer of divinylether and maleic anhydride
21. Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinylether-maleic acid copolymer
22. A lipophilic derivative of neocarzinostatin. A polymer conjugation of antitumor protein antibiotic
23. Conjugation of poly(styrene-co-maleic acid) derivative to the antitumor protein neocarzinostatin pronounced improvements in pharmacological properties
24. Protein binding of macromolecular anticancer agent SMANCS: characterization of poly(styrene-comaleic acid) derivatives as an albumin binding ligand
25. Tumor targeting by arterial administration of lipids: rabbit model with VX-2 carcinoma in the liver
26. Stimulation of macrophage by polyanion and its conjugated proteins and effect on cell membrane
27. Interferon induction by smancs. A polymer conjugated derivative of neocarzinostatin
28. Role of natural killer cells and macrophages on the nonspecific resistance to tumors in mice stimulated with SMANCS
29. Stability of high molecular weight anticancer agent smancs and its transfer from oil-phase to water-phase: comparative study with neocarzinostatin
30. A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II
31. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report
32. Targeting chemotherapy of hepatocellular carcinoma: Arterial administration of Smancs/Lipiodol